Yuka Ikegame

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Owing to the several advantages that they have over other cells, mesenchymal stem cells are among the most promising tools in stem cell therapy after ischemic stroke. Mesenchymal stem cells can be obtained from various sources. Therefore, a wide range of careful comparative studies of these cells is required, from the preclinical stage (in vitro and in(More)
  • 1